• Support Care Cancer · Apr 2006

    Case Reports

    Gabapentin in the treatment of severe sweating experienced by advanced cancer patients.

    • Giampiero Porzio, Federica Aielli, Lucilla Verna, Claudio Porto, Paolo Aloisi, Katia Cannita, Enrico Ricevuto, Paolo Marchetti, and Corrado Ficorella.
    • Supportive Care Task Force, Medical Oncology Department, University of L'Aquila, L'Aquila, Italy. porzio1@interfree.it
    • Support Care Cancer. 2006 Apr 1; 14 (4): 389-91.

    AbstractNine patients with advanced cancer suffering from idiopathic severe sweating were treated with gabapentin (600-1,800 mg/day). All patients responded to the treatment; five patients experienced transient drowsiness. Gabapentin seems to be a safe and effective treatment for idiopathic sweating in advanced cancer patients. Further studies are warranted to confirm or refute these results.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.